OC
CAPR icon

Oppenheimer & Co’s Capricor Therapeutics CAPR Stock Holding History

Oppenheimer & Co’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.94M Sell
63,666
-17,147
-21% -$457K 0.02% 604
2025
Q4 		$2.33M Sell
80,813
-54,600
-40% -$713K 0.03% 503
2025
Q3 		$976K Sell
135,413
-27,123
-17% -$200K 0.01% 902
2025
Q2 		$1.61M Buy
162,536
+33,341
+26% +$352K 0.02% 648
2025
Q1 		$1.23M Buy
129,195
+24,964
+24% +$347K 0.02% 714
2024
Q4 		$1.44M Buy
104,231
+35,823
+52% +$628K 0.02% 657
2024
Q3 		$1.04M Buy
68,408
+13,762
+25% +$68.1K 0.02% 775
2024
Q2 		$261K Buy
+54,646
New +$305K ﹤0.01% 1247

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return